Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Abbvie Inc (ABBV)

Abbvie Inc (ABBV)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 202,938,912
  • Shares Outstanding, K 1,766,222
  • Annual Sales, $ 45,804 M
  • Annual Income, $ 4,616 M
  • 60-Month Beta 0.83
  • Price/Sales 4.45
  • Price/Cash Flow 8.41
  • Price/Book 14.84
Trade ABBV with:

Options Overview

Details
  • Implied Volatility 21.66%
  • Historical Volatility 14.95%
  • IV Percentile 12%
  • IV Rank 15.50%
  • IV High 138.15% on 12/10/20
  • IV Low 0.29% on 12/16/20
  • Put/Call Vol Ratio 0.29
  • Today's Volume 20,762
  • Volume Avg (30-Day) 18,298
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 440,904
  • Open Int (30-Day) 410,854

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate 3.09
  • Number of Estimates 5
  • High Estimate 3.12
  • Low Estimate 3.06
  • Prior Year 2.34
  • Growth Rate Est. (year over year) +32.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
110.65 +3.84%
on 06/03/21
118.28 -2.86%
on 05/21/21
-1.99 (-1.70%)
since 05/17/21
3-Month
102.05 +12.59%
on 03/25/21
118.28 -2.86%
on 05/21/21
+9.86 (+9.39%)
since 03/17/21
52-Week
79.11 +45.24%
on 10/29/20
118.28 -2.86%
on 05/21/21
+19.16 (+20.01%)
since 06/17/20

Most Recent Stories

More News
AbbVie Declares Quarterly Dividend

/PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of per share. 

ABBV : 114.90 (-0.55%)
Global $7.78 Billion Anti-Parkinson Drugs Markets, 2015-2020, 2020-2025F, 2030F

/PRNewswire/ -- The report has been added to offering.

ABBV : 114.90 (-0.55%)
GSK : 40.57 (-0.22%)
NVS : 94.15 (+0.38%)
Aprea (APRE) Stock Rises as Leukemia Triplet Meets Study Goal

Aprea (APRE) announces that treatment with a combination regimen of its pipeline candidate, eprenetapopt, achieves 37% complete response rate in acute myeloid leukemia patients.

RHHBY : 47.4900 (-0.67%)
ABBV : 114.90 (-0.55%)
APRE : 5.04 (-6.32%)
BNTX : 214.20 (+5.08%)
Why AbbVie (ABBV) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.

ABBV : 114.90 (-0.55%)
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services

/PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering online healthcare information, professional training and educational services, today...

ZCMD : 1.7100 (-1.72%)
ABBV : 114.90 (-0.55%)
Global Infertility Drugs Market- Abbott Laboratories, AbbVie Inc., Bayer AG, Among Others to Contribute to the Market Growth

/PRNewswire/ --

ABT : 111.63 (+1.43%)
ABBV : 114.90 (-0.55%)
BAYRY : 15.9650 (-0.59%)
AbbVie (ABBV) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, AbbVie (ABBV) closed at $115.40, marking a -0.02% move from the previous day.

ABBV : 114.90 (-0.55%)
IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new data from the Phase 3 GLOW study comparing the efficacy and safety of the combination of IMBRUVICA (ibrutinib) plus VENCLEXTA/VENCLYXTO (venetoclax)...

ABBV : 114.90 (-0.55%)
New Data Shows AbbVie's VENCLYXTO®/VENCLEXTA® Fixed Duration Combination Demonstrates Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients after Three Years off Treatment

/PRNewswire/ -- AbbVie (NYSE: ABBV) today announced results from a four-year follow-up analysis of the Phase 3 CLL14 trial, which showed that previously untreated patients with chronic lymphocytic leukemia...

ABBV : 114.90 (-0.55%)
Retinal Biologics Market worth USD 34,891.44 Million by 2027, at 11.5% CAGR | Market Research Future (MRFR)

Retinal Biologics Market Overview:

ABBV : 114.90 (-0.55%)
AMGN : 240.76 (+0.49%)
REGN : 536.01 (+2.37%)
ONCE : 110.05 (-3.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

AbbVie is a global, research-based biopharmaceutical company. AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. The company's mission is to use its expertise, dedicated people and unique approach to innovation...

See More

Key Turning Points

3rd Resistance Point 117.71
2nd Resistance Point 116.80
1st Resistance Point 115.85
Last Price 114.90
1st Support Level 113.99
2nd Support Level 113.08
3rd Support Level 112.13

See More

52-Week High 118.28
Last Price 114.90
Fibonacci 61.8% 103.32
Fibonacci 50% 98.70
Fibonacci 38.2% 94.07
52-Week Low 79.11

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar